Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Debate Continues On Administration Of Magnesium Sulfate To Pregnant Women To Prevent Cerebral Palsy In Pre-Term Infants
Cerebral palsy (CP) is the most prevalent chronic childhood motor disability with an estimated lifetime cost of nearly $1 million per individual. There is evidence that magnesium sulfate (MgSO4) can reduce the incidence of CP for very early preterm infants. Many thousands of pregnant women and their fetuses are exposed to MgSO4 every year in the United States for a variety of indications, and most obstetricians are comfortable with its use. Yet, there is still some controversy over whether magnesium sulfate is truly protective against CP. In three articles published in the June 2009 issue of theAmerican Journal of Obstetrics & Gynecology, the authors shed some light on the debate.

First National Study To Examine Rock Climbing-Related Injuries
In the past decade the popularity of rock climbing has dramatically increased. It has been estimated that rock climbing is now enjoyed by more than 9 million people in the U.S. each year. A new study by researchers at the Center for Injury Research and Policy of the Research Institute at the Nationwide Children"s Hospital found that as the popularity of the sport has escalated, so have the number of injuries. Study findings revealed a 63 percent increase in the number of patients that were treated in U.S. emergency departments for rock climbing-related injuries between 1990 and 2007.
News of the day
Diabetes UK Launches Its National Measure Up Roadshows
Diabetes UK launches its national Measure Up Roadshow today to tackle the diabetes epidemic, as it reveals that more than 1.7 million people in the UK could have avoided developing Type 2 diabetes.
Health Insurance

Mayo Clinic Cancer Center Support Grant Renewed By NCI, Comprehensive Status Extended

The Mayo Clinic Cancer Center (MCCC) received an additional five years of National Cancer Institute (NCI) funding and re-designation as a comprehensive cancer center, according to Robert Diasio, M.D., the center"s director. Mayo Clinic has the only NCI-designated comprehensive cancer center conducting research at three distinct locations across the United States. The NCI Cancer Center Support Grant award to MCCC totals more than $28 million over five years for infrastructure and administrative support for cancer center researchers across Mayo"s three sites in Minnesota, Florida and Arizona. "The NCI renewal of Mayo"s Cancer Center Support Grant ensures the continuity of research programs that contribute to improved medical options for cancer patients," Dr. Diasio says. "This NCI grant is key in enabling Mayo Clinic to continue delivering outstanding care for its cancer patients." The MCCC is headquartered in Rochester, Minn., with research campuses in Scottsdale, Ariz., and Jacksonville, Fla. With NCI approval in 2003, MCCC incorporated its cancer research activity at its Minnesota, Florida and Arizona sites into a single, integrated institution. "The NCI recognized the Mayo Clinic Cancer Center for excellence in basic and clinical research, and for our contributions to cancer prevention, control and population sciences," Dr. Diasio says. "This award enables Mayo cancer researchers on all three of our campuses to build upon knowledge that leads to changes in medical practice which means improved treatment opportunities for our patients." Within its scope as a NCI-designated comprehensive cancer center, the MCCC designs and develops translational clinical studies that arise from collaborations between scientists and physicians. The 450 scientists and physicians of the MCCC faculty across all three sites are organized into programs that focus on 12 key cancer research themes. They include Women"s Cancers, Neuro-Oncology, Hematologic (bloodborne) Malignancies, Gene and Virus Therapy, Developmental Therapeutics, Genetic Epidemiology and Risk Assessment, Immunology and Immunotherapy, Gastrointestinal Cancers, Prostate Cancer, Cell Biology, Cancer Imaging, and Cancer Prevention and Control. Karl Oestreich Mayo Clinic


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009